← back to search

Laurèl Rauschenbach

Düsseldorf University Hospital ·
Area of research
Neurology · Genetics
Research interest
Research interests include Intracranial Aneurysms: Treatment and Complications, Glioma Diagnosis and Treatment, Vascular Malformations Diagnosis and Treatment, and Intracerebral and Subarachnoid Hemorrhage Research.
h-index
20
citations
1,346
works
182
NIH funding
primary concept
email

Recent publications

Additional file 3 of Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study
Figshare 2026cited by 0position: middledoi
Additional file 3 of Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study
Figshare 2026cited by 0position: middledoi
Additional file 2 of Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study
Figshare 2026cited by 0position: middledoi
Additional file 2 of Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study
Figshare 2026cited by 0position: middledoi
Additional file 1 of Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study
Figshare 2026cited by 0position: middledoi
Additional file 1 of Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study
Figshare 2026cited by 0position: middledoi
Comparing laminectomy and unilateral hemilaminectomy in spinal hemangioblastoma resection: A multicenter study
Brain and Spine 2026cited by 0position: middledoi
Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and von Hippel–Lindau disease: A multicenter study
Neuro-Oncology 2025cited by 4position: middledoi
Pediatric Intracranial Infections Requiring Neurosurgery: A German Multicenter Analysis of 10-Year Trends Pre–COVID-19 and Post–COVID-19
Neurosurgery 2025cited by 3position: middledoi
Treatment of Central Neurocytoma
Cancers 2025cited by 1position: middledoi
Prognostic relevance of MIB-1 labeling index in VHL-associated and sporadic spinal hemangioblastomas: a subgroup analysis from a multicentric study
Acta Neuropathologica Communications 2025cited by 1position: middledoi
Comparing Laminectomy and Unilateral Hemilaminectomy in Spinal Hemangioblastoma Resection: A Multicenter Study
Brain and Spine 2025cited by 0position: middledoi
Comparing Laminectomy and Unilateral Hemilaminectomy in Spinal Hemangioblastoma Resection: A Multicenter Study
Brain and Spine 2025cited by 0position: middledoi
Local tumor control and neurological outcomes after surgery for spinal hemangioblastomas in sporadic and Von-Hippel-Lindau Disease: A multicenter study
Brain and Spine 2025cited by 0position: middledoi
Cranioencephalic functional lymphoid units in glioblastoma
Nature Medicine 2024cited by 41position: middledoi
Predictors and surgical outcome of hemorrhagic metastatic brain malignancies
Journal of Neuro-Oncology 2024cited by 8position: firstdoi
Individual glioblastoma cells harbor both proliferative and invasive capabilities during tumor progression
Neuro-Oncology 2023cited by 51position: middledoi
KDM5B predicts temozolomide-resistant subclones in glioblastoma
iScience 2023cited by 4position: middledoi
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
Clinical Cancer Research 2022cited by 4position: middledoi
Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression
Nature Communications 2021cited by 54position: middledoi
Surgical treatment of brainstem cavernous malformations: an international Delphi consensus
Journal of neurosurgery 2021cited by 29position: middledoi
How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis
Cancers 2021cited by 25position: middledoi
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomography
Journal of Neuro-Oncology 2021cited by 19position: middledoi
The genetic landscape of choroid plexus tumors in children and adults
Neuro-Oncology 2020cited by 59position: middledoi
Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma
European Journal of Cancer 2020cited by 22position: firstdoi
Preoperative and early postoperative seizures in patients with glioblastoma—two sides of the same coin?
Neuro-Oncology Advances 2020cited by 18position: middledoi
Challenging Implications of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids Syndrome with an Atypical Presentation: Report of Two Cases
World Neurosurgery 2020cited by 7position: firstdoi
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors
Journal of Translational Medicine 2019cited by 78position: middledoi
Olfactory function as an independent prognostic factor in glioblastoma
Neurology 2019cited by 11position: middledoi
Xenografting for disease modeling of intramedullary spinal cord tumors: a systematic review
Spinal Cord 2019cited by 2position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Björn Scheffler · German Cancer Research Center13 papers (2018–2024)Martin Glas · German Cancer Research Center11 papers (2018–2023)Sied Kebir · German Cancer Research Center11 papers (2018–2024)Ulrich Sure · University of Duisburg-Essen10 papers (2019–2025)Ramazan Jabbarli · Deutschen Konsortium für Translationale Krebsforschung6 papers (2019–2025)Marvin Darkwah Oppong · Essen University Hospital6 papers (2020–2025) · 5 papers (2019–2025)Daniela Pierscianek · University of Duisburg-Essen5 papers (2019–2021)Celia Dobersalske · Düsseldorf University Hospital4 papers (2020–2024)Niklas Schäfer · University Hospital Bonn4 papers (2018–2021) · 4 papers (2020–2025)Lazaros Lazaridis · Universitätsklinikum Knappschaftskrankenhaus Bochum4 papers (2018–2021) · 4 papers (2020–2025)Ulrich Herrlinger · Brain (Germany)4 papers (2018–2021) · 3 papers (2018–2020)Christoph Kleinschnitz · Essen University Hospital3 papers (2019–2021)Matthias Simon · Evangelisches Krankenhaus Bielefeld3 papers (2019–2023)Alejandro N. Santos · Royal Adelaide Hospital3 papers (2020–2024)Martin Stuschke · German Cancer Research Center3 papers (2020–2021)Vivien Ullrich · Deutschen Konsortium für Translationale Krebsforschung3 papers (2020–2023)